Lilly provides 2013 outlook, reiterates 2012 guidance

Eli Lilly and Co. (NYSE:LLY) added $2.1 billion in market cap on Friday after introducing 2013 EPS and revenue guidances above the Street's estimates and reiterating its 2012 guidance. The pharma's market cap is now $59.8 billion. Lilly expects 2013 non-GAAP EPS of $3.75-$3.90, above the Street's estimate of $3.71, and 2013 revenue of $22.6-$23.4 billion. The Street is expecting $22.8 billion. Lilly also expects 2013 operating expenses to be flat to slightly down from 2012. ...